Maven Securities LTD - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CEREW and the CUSIP is 15678U102. A total of 25 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2021$855,000
+319.1%
56,6670.0%0.03%
+277.8%
Q1 2021$204,000
-39.6%
56,6670.0%0.01%
-72.7%
Q4 2020$338,00056,6670.03%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q2 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 72,466$409,0000.22%
Altium Capital Management LP 64,666$365,0000.14%
Nantahala Capital Management 283,332$4,307,0000.13%
Governors Lane LP 196,034$1,108,0000.09%
SPHERA FUNDS MANAGEMENT LTD. 166,332$940,0000.08%
Monashee Investment Management LLC 99,998$565,0000.08%
Context Capital Management, LLC 85,967$486,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 75,400$1,250,0000.05%
Maven Securities LTD 56,667$338,0000.03%
Walleye Capital LLC 70,649$399,0000.03%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders